Cosmos Health Inc. (COSM)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
---|---|---|---|---|
Revenue | 14,745,702 | 13,712,528 | 12,411,048 | 13,206,717 |
Cost of goods sold | 13,581,888 | 11,662,729 | 11,204,186 | 12,439,469 |
Gross profit | 1,163,814 | 2,049,799 | 1,206,862 | 767,248 |
Sales and marketing expenses | 21,706 | 28,155 | 41,848 | 110,813 |
Salaries and wages | 1,868,443 | 1,040,019 | 1,317,782 | 1,454,862 |
Research and development costs | 74,637 | 15,629 | - | - |
General and administrative expenses | 1,490,485 | 1,478,702 | 1,782,957 | 1,390,525 |
Depreciation and amortization expense | 353,862 | 320,439 | 304,139 | 313,074 |
Total operating expenses | 3,809,133 | 2,882,944 | 3,446,726 | 3,269,274 |
Loss from operations | -2,645,319 | -833,145 | -2,239,864 | -2,502,026 |
Foreign currency transaction, net | - | 175,824 | 139,016 | 180,701 |
Gain on equity investments, net | - | 3,142 | - | - |
Other income (expense), net | -42,190 | -68,137 | -1,921 | -29,305 |
Non-cash interest expense | 163,103 | - | - | - |
Interest income | 105,787 | 91,326 | 101,236 | 102,030 |
Interest expense | 388,814 | 187,107 | 181,429 | 342,446 |
Gain on equity investments, net | 2,639 | - | 428 | 335 |
Foreign currency transaction, net | 442,524 | - | - | - |
Change in fair value of convertible notes | -139,592 | - | - | - |
Total other income (expense), net | -182,749 | 15,048 | 57,330 | -88,685 |
Loss before income taxes | -2,828,068 | -818,097 | -2,182,534 | -2,590,711 |
Income tax expense | - | - | - | - |
Net loss | -2,828,068 | - | - | - |
Net loss attributable to common stockholders | -2,828,068 | -818,097 | -2,182,534 | -2,590,711 |
Foreign currency translation adjustment, net | 1,562,470 | 1,031,268 | 747,879 | -176,591 |
Deemed dividend | - | - | 6,185,231 | - |
Deemed dividend on warrant exchangemodification | - | - | -9,793 | - |
Net loss attributable to common stockholders | - | -818,097 | -8,377,558 | -2,590,711 |
Total comprehensive loss | -1,265,598 | 213,171 | -7,629,679 | -2,767,302 |
Basic | 28,753,492 | 26,037,608 | 18,418,287 | - |
Basic net loss per share | -0.1 | -0.03 | -0.45 | -0.15 |
Diluted | 28,753,492 | 26,037,608 | 18,418,287 | - |
Diluted net loss per share | -0.1 | -0.03 | -0.45 | -0.15 |